Vertex Pharmaceuticals Shares Outstanding History



Below is a table of the Vertex Pharmaceuticals shares outstanding history going back to 2/16/2010:

Date VRTX Shares Outstanding
2/16/2010200.58M
4/22/2010202.20M
7/29/2010202.83M
10/21/2010203.19M
2/9/2011204.41M
4/28/2011206.00M
7/29/2011208.09M
10/28/2011208.57M
2/8/2012210.34M
4/27/2012211.06M
7/27/2012215.81M
10/26/2012216.83M
2/15/2013218.19M
4/26/2013221.40M
7/26/2013232.81M
10/31/2013233.76M
2/5/2014235.77M
4/25/2014236.19M
7/25/2014238.08M
10/31/2014240.52M
1/15/2015242.09M
4/24/2015243.75M
7/24/2015244.66M
10/23/2015245.72M
1/31/2016246.39M
4/20/2016247.35M
7/22/2016247.78M
10/21/2016248.03M
2/10/2017248.44M
4/21/2017249.07M
7/21/2017252.12M
10/20/2017252.90M
1/31/2018253.89M
4/20/2018254.83M
7/20/2018255.56M
10/19/2018255.56M
1/31/2019255.66M
4/24/2019256.12M
7/26/2019257.04M
7/25/201917.18M
10/18/2019257.15M
1/31/2020259.27M
4/24/2020259.28M
7/23/2020260.47M
10/23/2020260.04M
1/31/2021259.96M
4/22/2021258.87M
7/23/2021259.43M
10/29/2021254.25M
1/31/2022254.58M
4/29/2022255.76M
7/29/2022256.46M
10/21/2022256.69M
1/31/2023257.09M
2/9/2024258.31M

Also see: VRTX Market Cap History
VRTX YTD Return
VRTX RSI
VRTX DMA
VRTX MACD
VRTX Technical Analysis
Vertex Pharmaceuticals Historical Shares Outstanding:
+1.82% CAGR
Vertex Pharmaceuticals Historical Shares Outstanding: +1.82% CAGR

Mouse over chart for data details
2/16/2010 ...2/9/2024
Vertex Pharmaceuticals is a biotechnology company. Co. has clinical and research programs to develop treatment of cystic fibrosis. In addition, Co. has a pipeline of investigational therapies in other diseases where it is utilizing insight into causal human biology, including sickle cell disease, beta thalassemia, APOL1-mediated kidney disease, type 1 diabetes, pain, alpha-1 antitrypsin deficiency, and muscular dystrophies. Co.'s marketed CF medicines are TRIKAFTA/KAFTRIO (elexacaftor/tezacaftor/ivacaftor and ivacaftor), SYMDEKO/SYMKEVI (tezacaftor in combination with ivacaftor), ORKAMBI (lumacaftor in combination with ivacaftor) and KALYDECO (ivacaftor). We show 55 historical shares outstanding datapoints in our coverage of VRTX's shares outstanding history.

Understanding the changing numbers of Vertex Pharmaceuticals shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like Vertex Pharmaceuticals versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching Vertex Pharmaceuticals by allowing them to research Vertex Pharmaceuticals shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree VRTX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Vertex Pharmaceuticals (VRTX) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

VRX Shares Outstanding History
VSAR Shares Outstanding History
VSTM Shares Outstanding History
VTGN Shares Outstanding History
VTL Shares Outstanding History
VTRS Shares Outstanding History
VTVT Shares Outstanding History
VTYX Shares Outstanding History
VVOS Shares Outstanding History
VVUS Shares Outstanding History
More Healthcare companies »

 

Vertex Pharmaceuticals Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.